PHIL Launches Direct-to-Patient 2.0 Platform

Read More »

September 22, 2025

Chris Amery Joins Alliant Insurance Services Northeast Benefits Team

Read More »

September 22, 2025

EMA Recommends Approval for Alvotech’s Gobivaz Biosimilar

Read More »

September 22, 2025

JCR Pharmaceuticals and Alexion Reach Milestone in Neurodegenerative Program

Read More »

September 19, 2025

TECVAYLI and DARZALEX FASPRO Show Strong Myeloma Response

Read More »

September 19, 2025

Health Canada Approves Stoboclo, Osenvelt Biosimilars to Prolia, Xgeva

Read More »

September 19, 2025

EU Approves Henlius, Organon Biosimilars to PROLIA, XGEVA

Read More »

September 19, 2025

ForCast and KORU Partner on New Antibiotic Infusion Therapy

Read More »

September 18, 2025

SAPHNELO TULIP-SC Phase III Trial Hits Primary Endpoint

Read More »

September 17, 2025

Tinostamustine Added to GBM AGILE Trial for Glioblastoma

Read More »

September 17, 2025

RazorMetrics Saves Texans $34 Million on Prescriptions in 2 years

Read More »

September 17, 2025

SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics

Read More »

September 16, 2025